Reducing risk and uncertainty in the drug development enterprise was an underlying theme in the activities of the National Academies’ Forum on Drug Discovery, Development, and Translation (the Forum) in 2012. In addition to leveraging opportunities to work with federal agencies, the Forum contributed to broad conversations on biomedical research and policy, including examining the benefits and barriers to sharing clinical research data to facilitate scientific and public health advances. The Forum membership focused on ways to address challenges in the U.S. clinical trials enterprise, facilitated a public dialogue on opportunities to accelerate the use of large simple trials, and fostered collaborative action to advance the development of a national certification system for clinical trial sites. Additionally, the Forum examined problems in the global drug supply chain for medicines to treat neglected diseases, such as multidrug-resistant tuberculosis.
For more information, please see https://www.nationalacademies.org/our-work/forum-on-drug-discovery-development-and-translation.
READ FREE ONLINE